Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Am J Physiol Cell Physiol ; 299(3): C643-53, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20573996

ABSTRACT

Hyperglycemia is an indication of poor outcome for heart attack patients, even for nondiabetic patients with stress-induced hyperglycemia. Previous studies showed that inhibition of aldose reductase, the first and rate-limiting enzyme of the polyol pathway, attenuated contractile dysfunction in diabetic animals, but the mechanism is unclear. We therefore wanted to find out whether the polyol pathway also contributes to acute hyperglycemia-induced cardiac contractile dysfunction, and determine the mechanism involved. Rat hearts were isolated and retrogradely perfused with Krebs buffer containing either normal or high concentrations of glucose for 2 h. Short exposure to high-glucose medium led to contractile dysfunction as indicated by decreased -dP/dt(max), as well as elevation in left ventricular end-diastolic pressure. Cardiomyocytes incubated in high-glucose medium showed abnormal Ca2+ signaling, most likely because of decreased activity of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) inactivated by oxidative stress. Inhibition of aldose reductase or sorbitol dehydrogenase, the second enzyme in the polyol pathway, ameliorated contractile dysfunction, attenuated oxidative stress, and normalized Ca2+ signaling and SERCA activity caused by high glucose, indicating that the polyol pathway is the major contributor to acute hyperglycemia-induced oxidative stress leading to the inactivation of SERCA and contractile dysfunction.


Subject(s)
Aldehyde Reductase/physiology , Heart/physiopathology , Hyperglycemia/metabolism , Oxidative Stress , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Signal Transduction , Acute Disease , Animals , Calcium Signaling , Glucose/pharmacology , Glutathione/metabolism , Hyperglycemia/physiopathology , In Vitro Techniques , Lactic Acid/metabolism , Male , Myocardial Contraction , Myocardium/metabolism , Oxidation-Reduction , Perfusion , Peroxynitrous Acid/metabolism , Pyruvic Acid/metabolism , Rats , Rats, Sprague-Dawley , Superoxides/metabolism , Tyrosine/metabolism
3.
J Mol Cell Cardiol ; 49(1): 58-69, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20025885

ABSTRACT

A number of studies have shown that the polyol pathway, consisting of aldose reductase (AR) and sorbitol dehydrogenase (SDH), contributes to ischemia-reperfusion (I/R)-induced myocardial infarction due to depletion of ATP. In this report we show that the polyol pathway in I/R heart also contributes to the impairment of sacro/endoplasmic reticulum Ca(2+)-ATPase (SERCA) and ryanodine receptor (RyR), two key players in Ca(2+) signaling that regulate cardiac contraction. Rat hearts were isolated and retrogradely perfused with either Krebs' buffer containing 1 microM AR inhibitor, zopolrestat, or 200 nM SDH inhibitor, CP-170,711, and challenged by 30 min of regional ischemia and 45 min of reperfusion. We found that post-ischemic contractile function of the isolated perfused hearts was improved by pharmacological inhibition of the polyol pathway. I/R-induced contractile dysfunction is most likely due to impairment in Ca(2+) signaling and the activities of SERCA and RyR. All these abnormalities were significantly ameliorated by treatment with ARI or SDI. We showed that the polyol pathway activities increase the level of peroxynitrite, which enhances the tyrosine nitration of SERCA and irreversibly modifies it to form SERCAC674-SO(3)H. This leads to reduced level of S-glutathiolated SERCA, contributing to its inactivation. The polyol pathway activities also deplete the level of GSH, leading to decreased active RyR, the S-glutathiolated RyR. Thus, in I/R heart, inhibition of polyol pathway improved the function of SERCA and RyR by protecting them from irreversible oxidation.


Subject(s)
Heart/physiopathology , Ryanodine Receptor Calcium Release Channel/metabolism , Aldehyde Reductase/antagonists & inhibitors , Aldehyde Reductase/metabolism , Animals , Benzothiazoles , L-Iditol 2-Dehydrogenase/metabolism , Male , Myocardial Contraction , Myocardial Infarction/metabolism , Myocardial Infarction/physiopathology , Myocardial Ischemia/metabolism , Myocardial Ischemia/physiopathology , Myocardial Reperfusion , Oxidation-Reduction , Phthalazines , Polymers , Proteins/metabolism , Rats , Rats, Sprague-Dawley
4.
J Biol Chem ; 278(36): 34003-10, 2003 Sep 05.
Article in English | MEDLINE | ID: mdl-12824177

ABSTRACT

AMP-activated kinase (AMPK) is a fuel-sensing enzyme present in most mammalian tissue. In response to a decrease in the energy state of a cell AMPK is phosphorylated and activated by still poorly characterized upstream events. Exposure of bovine aortic endothelial cells (BAEC) to chemically synthesized ONOO- acutely and significantly increased phosphorylation of c-Src, PDK1, AMPK, and its downstream target, acetyl-CoA carboxylase (ACC), without affecting cellular AMP. This novel pathway for AMPK activation was confirmed by the use of pharmacological inhibitors and dominant-negative mutants. Exposure of BAEC to hypoxia-reoxygenation (H/R) caused a biphasic increase in AMPK and ACC phosphorylation, which was prevented by adenoviral overexpression of superoxide dismutase (SOD) or inhibition of nitric-oxide synthase (NOS) implicating a role of ONOO- formed during H/R. Furthermore, dominant-negative mutants of c-Src or kinase-defective PDK1 also blocked H/R-induced AMPK activation indicating that, as with addition of exogenous ONOO-, both c-Src and PI 3-kinase are upstream of AMPK. Moreover, H/R, like ONOO-, significantly increased co-immunoprecipitation of AMPK with c-Src, suggesting that ONOO- favors physical association of AMPK with upstream kinases. Taken together, our results indicate a novel pathway by which H/R via ONOO- activates AMPK in a c-Src-mediated, PI 3-kinase-dependent manner, and suggest that ONOO--induced activation of AMPK might thereby regulate metabolic enzymes, such as ACC.


Subject(s)
Aorta/metabolism , Endothelium, Vascular/metabolism , Hypoxia , Multienzyme Complexes/metabolism , Peroxynitrous Acid/physiology , Phosphatidylinositol 3-Kinases/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins pp60(c-src)/metabolism , 3-Phosphoinositide-Dependent Protein Kinases , AMP-Activated Protein Kinases , Acetyl-CoA Carboxylase/chemistry , Adenoviridae/metabolism , Adenylate Kinase/metabolism , Animals , Cattle , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Activation , Models, Biological , Oxygen/metabolism , Peroxynitrous Acid/chemistry , Peroxynitrous Acid/metabolism , Phosphorylation , Precipitin Tests , Superoxide Dismutase/metabolism , Time Factors , Transfection
5.
J Biol Chem ; 277(36): 32552-7, 2002 Sep 06.
Article in English | MEDLINE | ID: mdl-12107173

ABSTRACT

Peroxynitrite (ONOO(-)), a nitric oxide-derived oxidant, uncouples endothelial nitric oxide synthase (eNOS) and increases enzymatic production of superoxide anions (O(2)()) (Zou, M. H., Shi, C., and Cohen, R. A. (2002) J. Clin. Invest. 109, 817-826). Here we studied how ONOO(-) influences eNOS activity. In cultured bovine aortic endothelial cells (BAEC), ONOO(-) increased basal and agonist-stimulated Ser(1179) phosphorylation of eNOS, whereas it decreased nitric oxide production and bioactivity. However, ONOO(-) strongly inhibited the phosphorylation and activity of Akt, which is known to phosphorylate eNOS-Ser(1179). Moreover, expression of an Akt dominant-negative mutant did not prevent ONOO(-)-enhanced eNOS-Ser(1179) phosphorylation. In contrast to Akt, ONOO(-) significantly activated 5'-AMP-activated kinase (AMPK), as evidenced by its increased Thr(172) phosphorylation as well as increased Ser(92) phosphorylation of acetyl-coenzyme A carboxylase, a downstream target of AMPK. Associated with the increased release of O(2)(), ONOO(-) significantly increased the co-immunoprecipitation of eNOS with AMPK. Further, overexpression of the AMPK-constitutive active adenovirus significantly enhanced ONOO(-) up-regulated eNOS-Ser(P)(1179). In contrast, overexpression of a dominant-negative AMPK mutant attenuated the ONOO(-)-enhanced eNOS-Ser(1179) phosphorylation as well as O(2)() release. We conclude that ONOO(-) inhibits Akt and increases AMPK-dependent Ser(1179) phosphorylation of eNOS resulting in enhanced O(2)() release.


Subject(s)
Multienzyme Complexes/metabolism , Nitric Oxide Synthase/metabolism , Peroxynitrous Acid/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Serine/metabolism , AMP-Activated Protein Kinases , Adenoviridae/genetics , Animals , Arginine/pharmacokinetics , Blotting, Western , Cattle , Cells, Cultured , Cyclic GMP/metabolism , Endothelium, Vascular/cytology , Enzyme Activation , Genes, Dominant , Mutation , Nitric Oxide Synthase Type III , Oxygen/metabolism , Phosphorylation , Precipitin Tests , Proto-Oncogene Proteins c-akt , Time Factors , Transfection , Up-Regulation , Zinc/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...